{"schema_version":"secwatch.filing_event.v1","accession":"0001764013-25-000009","form_type":"8-K","ticker":"IMVT","cik":"0001764013","company_name":"Immunovant, Inc.","filed_at":"2025-01-14T23:59:59+00:00","discovered_at":"2026-05-14T18:03:04.779822+00:00","generated_at":"2026-05-28T02:10:08.461312+00:00","sec_items":["7.01","9.01"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.1,"calibrated_materiality_score":0.1,"confidence":"low","headline":"Immunovant presents corporate overview at J.P. Morgan Healthcare Conference; no new data disclosed","bullets":["Presentation on January 14, 2025 covers autoimmune pipeline and tailored science approach.","No specific clinical results, financial updates, or guidance changes provided in the filing.","Filed under Regulation FD; presentation not incorporated by reference into SEC filings."],"urls":{"canonical":"https://secwatch.observer/filing/0001764013-25-000009","json":"https://secwatch.observer/filing/0001764013-25-000009.json","markdown":"https://secwatch.observer/filing/0001764013-25-000009.md","text":"https://secwatch.observer/filing/0001764013-25-000009.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1764013/000176401325000009/0001764013-25-000009-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1764013/000176401325000009/imvt-20250114.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-28T02:10:08.461312+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}